DUBLIN, Feb. 23, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/qcgw6r/anticoagulants) has announced the addition of the "Anticoagulants - Global Strategic Analysis" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020.
Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
This report analyzes the worldwide markets for Anticoagulants in US$ Million by the following Segments: Oral Anticoagulants, and Injectable Anticoagulants (Unfractionated Heparin, and Low Molecular Weight Heparin).
The report profiles 51 companies including many key and niche players such as
Key Topics Covered:
1. GLOBAL MARKET OVERVIEW
2. MARKET TRENDS & ISSUES
3. SEGMENT ANALYSIS
4. THERAPEUTIC INDICATIONS
5. PRODUCT INTRODUCTIONS/APPROVALS
6. RECENT INDUSTRY ACTIVITY
7. FOCUS ON SELECT GLOBAL PLAYERS
8. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 51 (including Divisions/Subsidiaries 59)
For more information visit http://www.researchandmarkets.com/research/qcgw6r/anticoagulants
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article